|
|
||||||||
1From the Departments of Pharmacology and Neuroscience and 3Pathology and Anatomy, the 5Division of Cell Biology and Genetics, and the 6North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, Texas; the 2Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida; and 4MitoKor, San Diego, California.
PURPOSE. Epidemiologic studies demonstrate a higher incidence of cataracts in estrogen-deprived postmenopausal women, but the mechanism for the increased risk of cataracts is unclear. An elevated level of H2O2 in aqueous humor and whole lenses has been associated with cataractogenesis. In the present study, for the first time, the protective effect of estrogens against oxidative stress were tested in cultured human lens epithelial cells (HLECs).
METHODS. To investigate the involvement of 17ß-estradiol (17ß-E2) in protection against oxidative stress, HLECs were exposed to insult with H2O2 at a physiological level (100 µM) over a time course of several hours, with and without pretreatment with 17ß-E2. Cell viability was measured by calcein AM assay, and 2',7'-dichlorofluorescein diacetate (DCFH-DA) was used to determine intracellular reactive oxygen species (ROS). Intracellular adenosine triphosphate (ATP) level was quantified with a luciferin- and luciferase-based assay and mitochondrial potential (
m) was monitored by a fluorescence resonance energy-transfer technique.
RESULTS. H2O2 caused a dose-dependent decrease in mitochondrial membrane potential, intracellular ATP levels, and cell viability. Dose-dependent increases in cell viability and intracellular ATP level were observed with pretreatment of 17ß-E2 for 2 hours before oxidative insult. At 1 nM, 17ß-E2 increased cell viability from 39% ± 4% to 75% ± 3%, and at 100 nM or higher, it increased survival to greater than 95%. The level of intracellular ATP approached normal with 17ß-E2 at 100 nM or higher. Pretreatment with 17ß-E2 did not diminish intracellular ROS accumulation after exposure to H2O2. Moreover, two nonfeminizing estrogens, 17
-E2 and ent-E2, both of which do not bind to either estrogen receptor
or ß, were as effective as 17ß-E2 in the recovery of cell viability. The estrogen receptor antagonist, ICI 182,780, did not block protection by 17ß-E2. Both 17ß- and 17
-E2 moderated the collapse of 
m in response to either H2O2 or excessive Ca2+ loading.
CONCLUSIONS. The present study indicates that both 17
- and 17ß-E2 can preserve mitochondrial function, cell viability, and ATP levels in human lens cells during oxidative stress. Although the precise mechanism responsible for protection by the estradiols against oxidative stress remains to be determined, the ability of nonfeminizing estrogens, which do not bind to estrogen receptors, to protect against H2O2 toxicity indicates that this conservation is not likely to be mediated through classic estrogen receptors.
This article has been cited by other articles:
![]() |
J. M. Flynn, S. D. Dimitrijevich, M. Younes, G. Skliris, L. C. Murphy, and P. R. Cammarata Role of wild-type estrogen receptor-{beta} in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E637 - E647. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Flynn, D. A. Lannigan, D. E. Clark, M. H. Garner, and P. R. Cammarata RNA suppression of ERK2 leads to collapse of mitochondrial membrane potential with acute oxidative stress in human lens epithelial cells Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E589 - E599. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Spoerl, V. Zubaty, F. Raiskup-Wolf, and L. E Pillunat Oestrogen-induced changes in biomechanics in the cornea as a possible reason for keratectasia Br. J. Ophthalmol., November 1, 2007; 91(11): 1547 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhao, K. O'Neill, and R. D. Brinton Estrogenic Agonist Activity of ICI 182,780 (Faslodex) in Hippocampal Neurons: Implications for Basic Science Understanding of Estrogen Signaling and Development of Estrogen Modulators with a Dual Therapeutic Profile J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1124 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nickerson, S. L. Kennedy, J. D. Johnson, and M. Fleshner Sexual dimorphism of the intracellular heat shock protein 72 response J Appl Physiol, August 1, 2006; 101(2): 566 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. A. Dykens, E. Perez, R. Liu, S. Yang, D. F. Covey, and J. W. Simpkins Neuroprotective Effects of 17beta-Estradiol and Nonfeminizing Estrogens against H2O2 Toxicity in Human Neuroblastoma SK-N-SH Cells Mol. Pharmacol., July 1, 2006; 70(1): 395 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, J. Li, A. Lulla, B. M. Evers, and D. H. Chung Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-{delta} pathway activation Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1469 - C1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chwa, S. R. Atilano, V. Reddy, N. Jordan, D. W. Kim, and M. C. Kenney Increased Stress-Induced Generation of Reactive Oxygen Species and Apoptosis in Human Keratoconus Fibroblasts Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1902 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Singh, J. A. Dykens, and J. W. Simpkins Novel Mechanisms for Estrogen-Induced Neuroprotection. Experimental Biology and Medicine, May 1, 2006; 231(5): 514 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pedram, M. Razandi, D. C. Wallace, and E. R. Levin Functional Estrogen Receptors in the Mitochondria of Breast Cancer Cells Mol. Biol. Cell, May 1, 2006; 17(5): 2125 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chiba, Y. Yamashita, M. Ueno, H. Fujisawa, K. Hirayoshi, K.-i. Hohmura, H. Tomimoto, I. Akiguchi, M. Satoh, A. Shimada, et al. Cultured Murine Dermal Fibroblast-Like Cells From Senescence-Accelerated Mice as In Vitro Models for Higher Oxidative Stress Due to Mitochondrial Alterations J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2005; 60(9): 1087 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Huppenbauer, L. Tanzer, L. L. DonCarlos, and K. J. Jones Gonadal Steroid Attenuation of Developing Hamster Facial Motoneuron Loss by Axotomy: Equal Efficacy of Testosterone, Dihydrotestosterone, and 17-{beta} Estradiol J. Neurosci., April 20, 2005; 25(16): 4004 - 4013. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |